Nutrition and cancer: The herbal revolution

Current Opinion in Gastroenterology

Volumn 15, Issue 2, 1999, Pages 177-180

  Wargovich, Michael J ^a  

^a South Carolina Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRACE ELEMENT;

CANCER; CANCER RESEARCH; CANCER RISK; DIETARY INTAKE; FRUIT; HUMAN; NUTRITION; PHYTOCHEMISTRY; PLANT; PUBLIC HEALTH; REVIEW; VEGETABLE;

EID: 0033046356     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-199903000-00016     Document Type: Review

References (50)

1. 1 Steinmetz KA, Potter JD: Vegetables, fruits, and cancer: I. epidemiology. Cancer Causes Control 1991, 2:325-357.
2. 2 Steinmetz KA, Potter JD: Vegetables, fruits, and cancer: II. mechanisms. Cancer Causes Control 1991, 2:427-442.
3. 3 Lupton JR, Coder DM, Jacobs LR: Long-term effects of fermentable fibers on rat colonic pH and epithelial cell cycle. J Nutr 1988, 118:840-845.
4. 4 Arbman G, Axelson O, Ericsson Begodzki AB, Fredriksson M, Nilsson E, Sjodahl R: Cereal fiber, calcium, and colorectal cancer. Cancer 1992, 69:2042-2048.
5. 5 Reddy BS, Simi B, Engle A: Biochemical epidemiology of colon cancer: effects of types of dietary fiber on colonic diacylglycerols in women. Gastroenterology 1994, 106:883-889.
6. 6 Decosse JJ, Miller HH, Lesser ML: Effect of wheat fiber and vitamins C and E on rectal polyps in patients with familial adenomatous polyposis. J Natl Cancer Inst 1989, 81:1290-1297.
7. 7 Shibata A, Paganini Hill A, Ross RK, Henderson BE: Intake of vegetables, fruits, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: a prospective study. Br J Cancer 1992, 66:673-679.
8. 8 Omenn GS, Goodman G, Thornquist M, Barnhart S, Balmes J, Cherniack M, et al: Chemoprevention of lung cancer: the beta-Carotene and Retinol Efficacy Trial (CARET) in high-risk smokers and asbestos-exposed workers. IARC Sci Publ 1996, 136:67-85.
9. 9 Smigel K: Beta carotene fails to prevent cancer in two major studies; CARET intervention stopped [news]. J Natl Cancer Inst 1996, 88:145.
10. 10 Rautalahti M, Albanes D, Virtamo J, Taylor PR, Huttunen JK, Heinonen OP: Beta-carotene did not work: aftermath of the ATBC study. Cancer Lett 1997, 114:235-236.
11. 11 Albanes D, Heinonen OP, Huttunen JK, Taylor PR, Virtamo J, Edwards BK, et al: Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. Am J Clin Nutr 1995, 62:1427S-1430S.
12. 12 Bertelli AA, Giovannini L, Stradi R, Urien S, Tillement JP, Bertelli A: Evaluation of kinetic parameters of natural phytoalexin in resveratrol orally administered in wine to rats. Drugs Exp Clin Res 1998, 24:51-55.
13. 13 Rotondo S, Rajtar G, Manarini S, Celardo A, Rotillo D, De Gaetano G, et al: Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br J Pharmacol 1998, 123:1691-1699.
14. 14 Clement MV, Hirpara JL, Chawdhury SH, Pervaiz S: Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 1998, 92:996-1002.
15. 15 Mgbonyebi OP, Russo J, Russo IH: Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int J Oncol 1998, 12:865-869.
16. 16 Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, et al: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275:218-220. This study reports the exceptional chemopreventive activity of resveratrol in a number of cancer model assays. The unique ability of the compound to modulate all phases of carcinogenesis is noted.
17. 17 Conney AH, Lou YR, Xie JG, Osawa T, Newmark HL, Liu Y, et al: Some perspectives on dietary inhibition of carcinogenesis: studies with curcumin and tea. Proc Soc Exp Biol Med 1997, 216:234-245.
18. 18 Huang MT, Deschner EE, Newmark HL, Wang ZY, Ferraro TA, Conney AH: Effect of dietary curcumin and ascorbyl palmitate on azoxymethanol-induced colonic epithelial cell proliferation and focal areas of dysplasia. Cancer Lett 1992, 64:117-121.
19. 19 Nagabhushan M, Bhide SV: Curcumin as an inhibitor of cancer. J Am Coll Nutr 1992, 11:192-198.
20. 20 Rao CV, Reddy BS: Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon. Carcinogenesis 1993, 14:2219-2225.
21. 21 Rao CV, Rivenson A, Simi B, Reddy BS: Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res 1995, 55:259-266.
22. 22 Wargovich MJ, Chen CD, Jimenez A, Steele VE, Velasco M, Stephens LC, et al: Aberrant crypts as a biomarker for colon cancer-evaluation of potential chemopreventive agents in the rat. Cancer Epidemiol Biomarkers Prev 1996, 5:355-360.
23. 23 Dreosti IE, Wargovich MJ, Yang CS: Inhibition of carcinogenesis by tea: the evidence from experimental studies. Crit Rev Food Sci Nutr 1997, 37:761-770. This review discusses the considerable scientific evidence from animal models documenting the cancer chemopreventive aspects of green and black tea.
24. 24 Katiyar SK, Mukhtar H: Tea consumption and cancer. World Rev Nutr Diet 1996, 79:154-184.
25. 25 Yang CS, Lee MJ, Chen L, Yang GY: Polyphenols as inhibitors of carcinogenesis. Environ Health Perspect 1997, 105(suppl 4):971-976.
26. 26 Zhang Y, Talalay P, Cho CG, Posner GH: A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci USA 1992, 89:2399-2403.
27. 27 Chung FL, Kelloff G, Steele V, Pittman B, Zang E, Jiao D, et al: Chemopreventive efficacy of arylalkyl isothiocyanates and N-acetylcysteine for lung tumorigenesis in Fischer rats. Cancer Res 1996, 56:772-778.
28. 28 Huang Q, Lawson TA, Chung FL, Morris CR, Mervish SS: Inhibition by phenylethyl and phenylhexyl isothiocyanate of metabolism of and DNA methylation by N-nitrosomethylamylamine in rats. Carcinogenesis 1993, 14:749-754.
29. 29 Stoner GD, Morrissey DT, Heur YH, Daniel EM, Galati AJ, Wagner SA: Inhibitory effects of phenethyl isothiocyanate on N-nitrosobenyzylmethylamine carcinogenesis in the rat esophagus. Cancer Res 1991, 51:2063-2068.
30. 30 Wilkinson J, Clapper ML: Detoxication enzymes and chemoprevention. Proc Soc Exp Biol Med 1997, 216:192-200. This is an excellent review on the role of Phase 2 detoxification enzymes in the prevention of cancer.
31. 31 Fahey JW, Zhang Y, Talalay P: Broccoli sprouts: an exceptionally rich source of induces of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci U S A 1997, 94:10367-10372.
32. 32 Hecht SS; Approaches to chemoprevention of lung cancer based on carcinogens in tobacco smoke. Environ Health Perspect 1997, 105(suppl 4):955-963.
33. 33 Jiao D, Smith TJ, Yang CS, Pittman B, Desai D, Amin S, Chung FL: Chemopreventive activity of thiol conjugates of isothiocyanates for lung tumorigenesis. Carcinogenesis 1997, 18:2143-2147.
34. 34 Sumiyoshi H, Wargovich MJ: Chemoprevention of 1,2-dimethylhydrazine-induced colon cancer in mice by naturally occurring organosulfur compounds. Cancer Res 1990, 50:5084-5087.
35. 35 Wargovich MJ: Diallyl sulfide, a flavor component of garlic (Allium sativum), inhibits dimethylhydrazine-induced colon cancer. Carcinogenesis 1987, 8:487-489.
36. 36 Wargovich MJ, Imada O, Stephens LC: Initiation and post-initiation chemopreventive effects of diallyl sulfide in esophageal carcinogenesis. Cancer Lett 1992, 64:39-42.
37. 37 Clapper ML, Hoffman SJ, Tew KD: Glutathione-S-transferases in normal and malignant human colon tissue. Biochim Biophys Acta 1991, 1096:209-216.
38. 38 Wilkinson J, Clapper ML: Detoxication enzymes and chemoprevention. Proc Soc Exp Biol Med 1997, 216:192-200.
39. 39 Benson AB: Oltipraz: a laboratory and clinical review. J Cell Biochem 1993, 17F(suppl):278-291.
40. 40 Stayrook KR, McKinzie JH, Burke YD, Burke YA, Crowell PL: Induction of the apoptosis-promoting protein Bak by perillyl alcohol in pancreatic ductal adenocarcinoma relative to untransformed ductal epithelial cells. Carcinogenesis 1997, 18:1655-1658.
41. 2 three times per day. Gastrointestinal toxicities were the most common side effect, including nausea, vomiting, and diarrhea.
42. 42 Lantry LE, Zhang Z, Gao F, Crist KA, Wang Y, Kelloff GJ, et al: Chemopreventive effect of perillyl alcohol on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced tumorigenesis in (C3H/HeJ X A/J)F1 mouse lung. J Cell Biochem 1997, 27(suppl):20-25.
43. 43 Crowell PL: Monoterpenes in breast cancer chemoprevention. Breast Cancer Res Treat 1997, 46:191-197.
44. 44 Haag JD, Lindstrom MJ, Gould MN: Limonene-induced regression of mammary carcinomas. Cancer Res 1992, 52:4021-4026.
45. 45 Elegbede JA, Elson CE, Qureshi A, Tanner MA, Gould MN: Inhibition of DMBA-induced mammary cancer by the monoterpene d-limonene. Carcinogenesis 1984, 5:661-664.
46. 46 Heyne KE, Lippman SM, Hong WK: Chemoprevention in head and neck cancer. Hematol Oncol Clin North Am 1991, 5:783-795.
47. 47 Lippman SM, Benner SE, Hong WK: Chemoprevention: strategies for the control of cancer. Cancer 1993, 72:984-990.
48. 48 Papadimitrakopoulou VA, Hong WK, Lee JS, Martin JW, Lee JJ, Batsakis JG, Lippman SM: Low-dose isotretinoin versus beta-carotene to prevent oral carcinogenesis: long-term follow-up. J Natl Cancer Inst 1997, 89:257-258.
49. 49 Lippman SM, Toth BB, Batsakis JG, Weber RS, McCarthy KS, Hays GL, et al: Modulation by 13-cis retinoic acid of biologic markers as indicators of Intermediate endpoints in human oral carcinogenesis. Prog Clin Biol Res 1990, 339:179-191.
50. 50 Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kesller RC: Trends in alternative medicine use in the United States, 1990-1997. JAMA 1998, 280:1569-1575. This paper as well as the entire issue of the journal is devoted to the current status of use of alternative medicine in the United States.